Stay updated on Nivolumab in EBV+ Lymphoproliferative Disorders Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in EBV+ Lymphoproliferative Disorders Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in EBV+ Lymphoproliferative Disorders Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Two new update dates (2026-04-01 and 2026-03-31) were added to the study record history, and two older dates (2026-03-06 and 2026-03-05) were removed.
    Difference
    0.2%
    Check dated 2026-04-02T15:24:38.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.3 to v3.5.0 on the page.
    Difference
    0.1%
    Check dated 2026-03-19T05:57:57.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Added revision notes for v3.4.3 on 2026-03-05 and 2026-03-06; older revision v3.4.2 is listed under deletions.
    Difference
    0.3%
    Check dated 2026-03-12T02:22:02.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    New update entries were added for 2026-02-20, 2026-02-21, and 2026-02-24. Older update entries for 2026-02-14, 2026-02-17, and 2025-11-28 were removed.
    Difference
    0.3%
    Check dated 2026-02-25T18:54:02.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Adds two new study update dates (2026-02-14 and 2026-02-17) and removes two earlier dates (2026-01-15 and 2026-01-16). No core trial details, including eligibility, interventions, or outcomes, appear to be changed.
    Difference
    0.2%
    Check dated 2026-02-18T16:41:48.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    Page now shows Revision: v3.4.2 and the older Revision: v3.4.1 notice has been removed along with a government funding status notice. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T12:08:22.000Z thumbnail image

Stay in the know with updates to Nivolumab in EBV+ Lymphoproliferative Disorders Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in EBV+ Lymphoproliferative Disorders Clinical Trial page.